Search results for "Estro."

showing 10 items of 770 documents

Immunohistochemical expression of estrogens and progesterone receptors in carcinoma ex pleomorphic adenoma-undifferentiated and adenocarcinoma types.

2009

Cancer of the salivary gland is one of the common cancers in the head and the neck regions. This type of cancer develops in the minor and the major salivary glands, and it sometimes metastasizes to other organs, particularly the lung. Morphologic mimicry and similarity in the expression of steroid hormone receptors between salivary gland tumors and breast tumors are well-known phenomena and are occasionally debated in the field of surgical pathology. The expression of sex hormone receptors in some tumors suggests a role for these receptors in tumor pathogenesis and therapy. Previous studies of the expression of estrogens and progesterone receptors in salivary gland tumors have reported conf…

AdultMalePathologymedicine.medical_specialtyAdolescentmedicine.medical_treatmentAdenoma PleomorphicAdenocarcinomaPleomorphic adenomaNeoplasms Multiple PrimaryMajor Salivary GlandProgesterone receptormedicineHumansReceptorGeneral DentistryAgedAged 80 and overbusiness.industrySex hormone receptorMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Salivary Gland NeoplasmsImmunohistochemistrySteroid hormoneCarcinoma ex pleomorphic adenomaOtorhinolaryngologyReceptors EstrogenUNESCO::CIENCIAS MÉDICASAdenocarcinomaSurgeryFemalebusinessReceptors ProgesteroneMedicina oral, patologia oral y cirugia bucal
researchProduct

Presence of estrogen-binding sites on macrophage-like synoviocytes and cd8+, cd29+, cd45ro+ t lymphocytes in normal and rheumatoid synovium

1993

Objective. To study the presence of estrogen-binding sites (EBS) in the synovial tissues of male and female patients with rheumatoid arthritis (RA) and in age and sex-matched healthy controls. Methods. Both type 1 (high affinity, low binding capacity) and type 2 (reduced affinity, higher binding capacity) EBS were investigated in both soluble and nuclear fractions of homogenized synovial tissue samples by a dextran-coated charcoal method. To determine what type of synovial cell was positive for EBS, cryosections of synovial tissues were immunostained with a specific monoclonal anti–estrogen receptor antibody (anti-ER MAb) using both immunofluorescence and immunoperoxidase techniques. Double…

AdultMalePathologymedicine.medical_specialtyT-LymphocytesT cellImmunologyImmunofluorescenceArthritis RheumatoidRheumatologyAntigenmedicineHumansImmunology and AllergyPharmacology (medical)Estrogen bindingAgedSex Characteristicsmedicine.diagnostic_testbusiness.industryMacrophagesSynovial MembraneMiddle AgedImmunohistochemistryMolecular biologymedicine.anatomical_structureReceptors EstrogenSynovial CellFemaleSynovial membranebusinessImmunostainingCD8Arthritis & Rheumatism
researchProduct

Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients

2008

Background Hereditary angioedema (HAE) due to C1 inhibitor deficiency is clinically characterized by relapsing skin swellings, abdominal pain attacks, and life-threatening upper airway obstruction. Treatment with androgens prevents attacks for those with this condition. Objective To examine the benefits and risks of long-term treatment with danazol. Methods Data were generated retrospectively from 118 German and Danish patients who had HAE due to C1 inhibitor deficiency and were treated with danazol from 2 months to 30 years. The frequency and severity of acute attacks were registered before and during danazol treatment, and adverse effects to the treatment were noted. Data were collected b…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyAbdominal painPediatricsImmunologyDose-Response Relationship ImmunologicRisk AssessmentSeverity of Illness IndexEcallantideSeverity of illnessmedicineHumansImmunology and AllergyAdverse effectDepression (differential diagnoses)Retrospective StudiesDanazolbusiness.industryDanazolAngioedemas HereditaryEstrogen AntagonistsMiddle Agedmedicine.diseaseSurgeryDiscontinuationHereditary angioedemaFemalemedicine.symptombusinessFollow-Up Studiesmedicine.drugAnnals of Allergy, Asthma & Immunology
researchProduct

Acute responses of comprehensive gonadosteroids and corticosteroids to resistance exercise before and after 10 weeks of supervised strength training

2019

New Findings: What is the central question of this study? Although acute responses of the principal gonadosteroid and corticosteroid hormones to resistance exercise are well documented, there is no information regarding how the key lower-concentration intermediary hormones respond and potentially influence these hormonal pathways. What is the main finding and its importance? This study provides evidence for cascading conversions of some gonadosteroids, and the data suggest that the testosterone concentration increases independently of these hormones. These findings challenge future studies to determine the exact physiological roles of the lower-concentration gonadosteroids and corticosteroi…

AdultMalemedicine.medical_specialtyHydrocortisonePhysiologymedicine.drug_classStrength trainingmedicine.medical_treatmentDehydroepiandrosteroneEstrone030204 cardiovascular system & hematologyYoung Adult03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAdrenal Cortex HormonesPhysiology (medical)Internal medicineHumansMedicineKneeTestosteroneAndrostenedioneMuscle SkeletalExerciseHydrocortisoneNutrition and Dieteticsbusiness.industryResistance TrainingGeneral MedicineAdaptation PhysiologicalSteroid hormoneEndocrinologychemistryCorticosteroidbusiness030217 neurology & neurosurgeryHormonemedicine.drugExperimental Physiology
researchProduct

Correlations of female steroid hormone receptors with histologic features in meningiomas.

1991

A series of 39 samples were obtained from meningiomas in 28 patients in order to investigate the relationships of the oestrogen receptor (OER) and progesterone receptor (PR) with the tumoural subtype and some histological features. Twenty-one samples were positive (greater than 10 fmole/mg protein), 7 were OER-PR-negative, and 1 was positive in both receptors. Twenty-two samples were considered as syncitial, 7 transitional, 7 fibroblastic and 3 angioblastic. The histological subtype was not found to be significantly related to the presence or absence of PR. Relations were not observed between the progestin receptor and the following histological parameters: cellular pattern, cell density, n…

AdultMalemedicine.medical_specialtyNecrosisPsammoma bodymedicine.drug_classmedicine.medical_treatmentMitosisMeningiomaNecrosisInternal medicineProgesterone receptormedicineMeningeal NeoplasmsHumansReceptorAgedbusiness.industryHistologyMiddle Agedmedicine.diseaseSteroid hormoneEndocrinologyReceptors EstrogenEstrogenSurgeryFemaleNeurology (clinical)medicine.symptombusinessMeningiomaReceptors ProgesteroneActa neurochirurgica
researchProduct

Treatment of idiopathic oligozoospermia with tamoxifen--a randomized controlled study.

1992

There is no conclusive evidence of the usefulness of tamoxifen in the treatment of idiopathic oligozoospermia (OAT-syndrome), as it has been used mostly in uncontrolled studies. We herein report on the controlled treatment of OAT-syndrome with tamoxifen versus placebo following a randomized design. Seventy-six men with sperm counts of 2-20 x 10(6) ml-1, sperm motility of 20-50%, and sperm morphology (abnormal cells) between 50 and 80% were involved in the study. Patients with varicocele, a history of testicular maldescent or genital inflammation were excluded. Thirty-nine patients received tamoxifen (30 mg daily), 37 patients placebo. There was a statistically significant increase in the me…

AdultMalemedicine.medical_specialtyUrologyEndocrinology Diabetes and MetabolismVaricoceleUrologyPlacebolaw.inventionRandomized controlled triallawStatistical significanceInternal medicinemedicineHumansTestosteroneSperm motilitySperm Countbusiness.industryOligospermiaLuteinizing HormoneAntiestrogenmedicine.diseaseSpermTamoxifenEndocrinologyReproductive MedicineSperm MotilityFollicle Stimulating HormonebusinessTamoxifenmedicine.drugInternational journal of andrology
researchProduct

Estrogen and Progesterone hormone receptor expression in oral cavity cancer

2016

Background Recent studies have shown an increase in the incidence of oral squamous cell carcinoma (OSCC) in younger patients. The hypothesis that tumors could be hormonally induced during pregnancy or in young female patients without the well-known risk factors alcohol or tobacco abuse seems to be plausible. Material and Methods Estrogen Receptor alpha (ERα) and Progesterone Receptor (PR) expression were analyzed in normal oral mucosa (n=5), oral precursor lesions (simple hyperplasia, n=11; squamous intraepithelial neoplasia, SIN I-III, n=35), and OSCC specimen. OSCCs were stratified in a young female (n=7) study cohort and older patients (n=46). In the young female study cohort three patie…

AdultMalemedicine.medical_specialtymedicine.drug_classOral cavityYoung Adult03 medical and health sciences0302 clinical medicinePregnancyInternal medicineHumansMedicineYoung adultGeneral DentistryProgesteroneMouth neoplasmPregnancyOral Medicine and Pathologybusiness.industryResearchIncidence (epidemiology)Mouth MucosaCancerEstrogens030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseasestomatognathic diseasesEndocrinologyReceptors EstrogenOtorhinolaryngologyEstrogenHormone receptor030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASCarcinoma Squamous CellFemaleMouth NeoplasmsSurgeryReceptors Progesteronebusiness
researchProduct

Risk factors for clinical stress fractures in male military recruits: A prospective cohort study

2004

This prospective study was aimed at evaluating risk factors for symptomatic stress fractures among 179 Finnish male military recruits, aged 18 to 20 years. The subjects were studied in the very beginning of the military service of 6 to 12 months in summer. Bone mineral content (BMC) and density (BMD) were measured by dual energy X-ray absorptiometry (DXA) at the lumbar spine and at the hip and heel ultrasound investigation was performed. Blood was sampled for determination of serum total and free testosterone, total and free estradiol, sex hormone-binding globulin (SHBG), procollagen type I N propeptide, total and carboxylated osteocalcin, tartrate-resistant acid phosphatase 5b, 25-hydroxyv…

AdultMalemusculoskeletal diseasesmedicine.medical_specialtyHistologyAdolescentFractures StressBone densityPhysiologyEndocrinology Diabetes and MetabolismAcid PhosphataseOsteocalcinParathyroid hormoneCollagen Type IBone remodelingSex hormone-binding globulinN-terminal telopeptideBone DensityRisk FactorsSex Hormone-Binding GlobulinInternal medicinemedicineHumansTestosteroneProspective StudiesVitamin DProspective cohort studyFemoral neckPolymorphism GeneticStress fracturesEstradiolbiologyTartrate-Resistant Acid Phosphatasebusiness.industrymedicine.diseaseIsoenzymesMilitary Personnelmedicine.anatomical_structureEndocrinologyReceptors EstrogenParathyroid HormoneReceptors Androgenbiology.proteinbusinessBone
researchProduct

Effect of continuous oestradiol-medroxyprogesterone administration on plasma lipids and lipoproteins

1991

Plasma lipids and lipoproteins were measured in 21 post-menopausal women after 4 and 8 months of continuous treatment with an orally administered combination of oestradiol and medroxyprogesterone acetate. The mean concentrations of cholesterol and low-density-lipoprotein (LDL) cholesterol were reduced by 12% (P less than 0.001) and 11% (P less than 0.01), respectively, after 4 months of treatment and by 9% (P less than 0.05) and 12% (P less than 0.05) after 8 months. The mean level of high-density-lipoprotein (HDL) cholesterol showed an initial fall of 5% (P less than 0.05) after 4 months and then increased by 13% (P less than 0.05) after 8 months of treatment. The plasma triglycerides leve…

AdultMedroxyprogesteronemedicine.medical_specialtymedicine.drug_classLipoproteinsMedroxyprogesteronemedicine.medical_treatmentGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundInternal medicinePlasma lipidsHumansMedicineMedroxyprogesterone acetateClinical significanceProspective StudiesEstradiolProgestogenbusiness.industryCholesterolEstrogen Replacement TherapyObstetrics and GynecologyMiddle AgedLipidsEndocrinologychemistryEstrogenDrug Therapy CombinationFemalelipids (amino acids peptides and proteins)Menopausebusinessmedicine.drugLipoproteinMaturitas
researchProduct

Transforming Growth Factor Beta 1 Serum Levels in Patients with Preinvasive and Invasive Lesions of the Breast

2004

Transforming growth factor beta (TGF-beta)1 is thought to be involved in breast carcinogenesis. TGF-beta1 acts in an antiproliferative manner in the early stages of breast carcinogenesis, but promotes tumor progression and metastases in the advanced stages of the disease. No data have been published on serum TGF-beta1 in breast cancer. We investigated TGF-beta1 serum levels in patients with breast cancer (n=135), ductal carcinoma in situ (DCIS) I to III (n=67) or fibroadenoma (n=35), and in healthy women (n=40) to determine its value as a differentiation marker between malignant, pre-invasive and benign diseases and as a predictive marker for metastatic spread. Median (range) TGF-beta1 seru…

AdultOncology0301 basic medicinemedicine.medical_specialtyPathologyCancer ResearchMammary glandClinical BiochemistryCA 15-3Breast NeoplasmsPathology and Forensic MedicineTransforming Growth Factor beta103 medical and health sciencesBreast cancer0302 clinical medicineTransforming Growth Factor betaInternal medicinemedicineHumansNeoplasm Invasivenessskin and connective tissue diseasesEstrogen Receptor StatusAgedNeoplasm StagingAged 80 and overPredictive markerbusiness.industryMiddle AgedDuctal carcinomamedicine.diseaseFibroadenomamedicine.anatomical_structure030104 developmental biologyOncologyTumor progression030220 oncology & carcinogenesisbusinessThe International Journal of Biological Markers
researchProduct